Here are the DEF 14A proxy statements from Medinotec Inc (MDNC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow MDNC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MDNC filings page.
Medinotec Inc. is calling its 2025 Annual Meeting of Stockholders for January 20, 2026 at 9:30 a.m. EST, to be held exclusively via video conference. Only holders of common stock as of December 5, 2025 may vote, with one vote per share, and all voting must be completed in advance by email, mail or fax; shareholders cannot vote during the live meeting.
Investors are being asked to elect five directors, all current board members, and to approve Mercurius & Associates LLP as independent registered public accounting firm for the fiscal year ending February 28, 2026. The board recommends voting "FOR" all nominees and the auditor ratification.
As of the record date, 11,755,548 common shares were outstanding, with directors and executive officers as a group beneficially owning about 84.3%, including large positions held by Gregory and Stavros Vizirgianakis. The filing also highlights related-party arrangements, including a $940,001 loan from Minoan Medical and rent paid to an entity controlled by the CEO, as well as modest cash compensation reported for top executives.